CSF and amyloid pet biomarker data from scarlet road - a global Phase 3 study of gantenerumab in patients with prodromal AD
| Autor: | Dietmar Volz, Philip Scheltens, Christina Rabe, Susanne Ostrowitzki, Markus Schmitz, Luca Santarelli, Tania Nikolcheva, Bruno Dubois, Paulo Fontoura, Ernest Dorflinger, George Garibaldi, Tobias Bittner, Robert Lasser, Mercè Boada, Udo Eichenlaub, Chris J. Edgar |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
0301 basic medicine
Aging Pathology medicine.medical_specialty General Neuroscience Amyloid pet Phases of clinical research 03 medical and health sciences 030104 developmental biology 0302 clinical medicine medicine Biomarker (medicine) In patient Neurology (clinical) Geriatrics and Gerontology Psychology Gantenerumab 030217 neurology & neurosurgery Developmental Biology medicine.drug |
| Zdroj: | Neurobiology of Aging. 39:S28-S29 |
| ISSN: | 0197-4580 |
| DOI: | 10.1016/j.neurobiolaging.2016.01.124 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect